Furthermore, in terms of epigenetic regulation, it has been found that the ASPM–FOXM1 dual positive feedback loop promotes the progression of liver cancer via liquid–liquid-phase separation mechanisms, and that targeting this mechanism (e.g., by disrupting phase separation) may represent a novel therapeutic strategy [36]. Here, FOXM1 is linked to liver cancer.